Stock PRLD PRELUDE THERAPEUTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
3.86 USD +1.58% Intraday chart for Prelude Therapeutics Incorporated +4.32% -9.60%
05-07 Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-10 Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated CI
811b4e40d8.Cdu0R14kD9Hcy0jj_V2AWgovV1S7pI66KHm3z_RPb2c.eIHuC2hhVZKQ-z3RymjyIk5iID_v09f_HU7xuZ0AJgZlk9d-c2x_oeqDCQ~d21057224dc797b0902ffae79675d8bc
  1. Stock Market
  2. Equities
  3. PRLD Stock
  4. Charts Prelude Therapeutics Incorporated
  5. News Chart